MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Myriad Genetics Company Profile (NASDAQ:MYGN)

Consensus Ratings for Myriad Genetics (NASDAQ:MYGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $43.23 (27.37% upside)

Analysts' Ratings History for Myriad Genetics (NASDAQ:MYGN)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2016Leerink SwannLower Price TargetMarket Perform$44.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Avondale PartnersLower Price TargetMarket Outperform$50.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016MizuhoLower Price TargetNeutral$42.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Goldman SachsBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Deutsche BankReiterated RatingBuy$52.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Cowen and CompanyBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BarclaysBoost Price TargetOverweight$50.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/27/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/20/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2015StephensBoost Price TargetOverweight$42.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Jefferies GroupBoost Price TargetHold$32.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015JMP SecuritiesLower Price TargetMarket Outperform$46.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015GabelliInitiated CoverageBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit SuisseReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Cantor FitzgeraldReiterated RatingBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014Morgan StanleyInitiated CoverageUnderperform -> Underperform$25.00 -> $34.89View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014SunTrustBoost Price Target$22.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2014RBC CapitalBoost Price TargetSector Perform$31.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2014MacquarieReiterated RatingNeutral$38.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha